Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001610618-22-000023
Filing Date
2022-04-04
Accepted
2022-04-04 17:09:54
Documents
1
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_164910656863339.html 4  
1 FORM 4 wf-form4_164910656863339.xml 4 10000
  Complete submission text file 0001610618-22-000023.txt   11495
Mailing Address 6310 NANCY RIDGE DRIVE, SUITE 101 SAN DIEGO CA 92121
Business Address
Stein Jeffrey (Reporting) CIK: 0001478831 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36912 | Film No.: 22803618

Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Issuer) CIK: 0001610618 (see all company filings)

EIN.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)